Cannabis classification in the United Kingdom refers to the class of drugs, as determined by the Misuse of Drugs Act 1971, that cannabis is placed in. Between 1928 and 2004 and since 2009, it has been classified as a class B drug. From 2004 to 2009, it was a class C drug. At present, it is a class B, with very limited exceptions.
Drug policy (including Cannabis classification) has been a contentious subject in UK politics. A number of senior Scientific advisors have objected the transfer back to class B, notably Professor David Nutt and John Beddington considered the move politically motivated rather than scientifically justified. [1]
As Home Secretary in Tony Blair's Labour government, David Blunkett announced in 2001 that cannabis would be transferred from class B of the Act to class C, resulting in a penalty of up to 2 years in prison for possession. The penalty for possession would be up to 5 years in prison if it is decided that there was an intent to supply. [2] Reclassification had the support of a plurality of the public, with surveys at the time finding that 49% of British adults supported cannabis decriminalisation, 36% were against, and 15% were undecided. [3] The transfer eventually happened in January 2004, after class C penalties for distribution had been stiffened. The Advisory Council on the Misuse of Drugs had recommended such a reclassification as early as 1979, a view endorsed by the Runciman Report [4] in 1999.
The change was designed to enable police forces to concentrate resources on other (more serious) offences, including those involving "harder drugs". The government stated that the reclassification of cannabis to class C had the desired effect, with arrests for cannabis possession falling by one third in the first year following, saving an estimated 199,000 police hours. [5]
Early in January 2006 Charles Clarke, the Home Secretary, said that on the basis of advice from the Advisory Council, a decision was made not to return cannabis to class B. [6] However, during Prime Minister's Questions on 18 July 2007, Prime Minister Gordon Brown announced that the Home Secretary, Jacqui Smith, was reviewing again whether to return cannabis to class B status. [7] [8] On 7 May 2008, Smith confirmed that cannabis in the UK would again be classified as a class B drug, despite the Advisory Council's recommendation. [9] On 26 January 2009, cannabis was reclassified as a class B drug. [10] The reclassification of cannabis to a class B drug had been hinted at as early as 2005 by allies of Gordon Brown, on the election night in 2005, Ed Balls stated that cannabis and the war in Iraq were mistakes that the Labour party had to learn from. [11]
In October 2022, it was reported by The Sunday Times that the UK's Home Secretary, Suella Braverman, was considering upgrading cannabis to a class A drug. [12] This would place cannabis in the same category as heroin, cocaine and ecstasy. [13] This would mean that the maximum penalty for possession of cannabis would increase from five years in prison to seven years in prison, and increase the penalty for supply and production of cannabis from 14-years in prison to life in prison. [14] An increase in classification from class B to class A was called for by a group of Conservative Party police and crime commissioners at the 2022 Conservative Party conference. [13] Peter Reynolds, the president of the organisation, Cannabis Law Reform (CLEAR), said the idea was "completely crazy" and expanded by saying: [15]
The idea of doing more of the same as the past 50 years, which has quite obviously dramatically failed, is ridiculous. The only people who want this are ignorant politicians and the people who sell illegal drugs, I'm crystal clear about that. [15]
In 2012 the Home Affairs Select Committee produced a report on the UK's drugs policies. The committee were split on whether to recommend reducing the classification of cannabis back to class C. A vote was held in committee on the inclusion of the following sentence:
We remain, however, of the view expressed in our predecessors' Report, namely that cannabis be reclassified from class B to C, and therefore regret the decision taken by the Government in 2008
— The House of Commons, 2012 [16]
The vote was tied, 3:3, and the chair, Keith Vaz MP, voted to keep the sentence in the report and therefore recommend reducing the classification. [16]
On Tuesday 10 October 2017 under the Ten Minute Rule the Legalisation of Cannabis (Medicinal Purposes) Bill was proposed by Paul Flynn, Frank Field, Caroline Lucas, Mary Glindon, Jeff Smith, Kelvin Hopkins, Crispin Blunt, Michael Fabricant, Martyn Day, Ronnie Cowan, Layla Moran, and Alistair Carmichael. [17]
Rescheduling of cannabis and cannabis resin;(1) The Misuse of Drugs Regulations 2001 are amended as follows. (2) In paragraph 1(a) of Schedule 1, omit “Cannabis (not being the substance specified in paragraph 5 of Part 1 of Schedule 4) and cannabis resin”. (3) In paragraph 1 of Schedule 2, after “Bezitramide”, insert “Cannabis (not being the substance specified in paragraph 5 of Part 1 of Schedule 4) and cannabis resin” [18]
The first emergency licence for cannabis oil was granted on 18 June 2018. The concession came after an epileptic child became severely ill after having his cannabis confiscated. [19]
The prohibition of drugs through sumptuary legislation or religious law is a common means of attempting to prevent the recreational use of certain intoxicating substances.
The Misuse of Drugs Act 1971 is an act of the Parliament of the United Kingdom. It represents action in line with treaty commitments under the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
The Single Convention on Narcotic Drugs, 1961 is an international treaty that controls activities of specific narcotic drugs and lays down a system of regulations for their medical and scientific uses; it also establishes the International Narcotics Control Board.
The International Narcotics Control Board (INCB) is an independent treaty body, one of the four treaty-mandated bodies under international drug control law.
The Misuse of Drugs Act 1975 is a New Zealand drug control law that classifies drugs into three classes, or schedules, purportedly based on their projected risk of serious harm. However, in reality, classification of drugs outside of passing laws, where the restriction has no legal power, is performed by the governor-general in conjunction with the Minister of Health, neither of whom is actually bound by law to obey this restriction.
The Advisory Council on the Misuse of Drugs (ACMD) is a British statutory advisory non-departmental public body, which was established under the Misuse of Drugs Act 1971.
The Wootton Report on cannabis was compiled by the Sub-committee on Hallucinogens of the United Kingdom Home Office Advisory Committee on Drug Dependence. The sub-committee was chaired by Baroness Wootton of Abinger. Originally intended to be a report on both cannabis and LSD, the panel members decided to limit their report to cannabis.
Drug classification: making a hash of it? is a 2006 report written by the UK Science and Technology Select Committee and submitted to the British House of Commons. The report suggested that the current system of recreational drug classification in the UK was arbitrary and unscientific, suggesting a more scientific measure of harm be used for classifying drugs. The report also strongly criticised the decision to place fresh psychedelic mushrooms in Class A, the same category as cocaine and heroin.
The use of cannabis in New Zealand is regulated by the Misuse of Drugs Act 1975, which makes unauthorised possession of any amount of cannabis a crime. Cannabis is the fourth-most widely used recreational drug in New Zealand, after caffeine, alcohol and tobacco, and the most widely used illicit drug. In 2001 a household survey revealed that 13.4% of New Zealanders aged 15–64 used cannabis. This ranked as the ninth-highest cannabis consumption level in the world.
Cannabis in the United Kingdom is illegal for recreational use and is classified as a Class B drug. In 2004, the United Kingdom made cannabis a Class C drug with less severe penalties, but it was moved back to Class B in 2009. Medical use of cannabis, when prescribed by a registered specialist doctor, was legalised in November 2018.
Cannabis in Oregon is legal for both medical and recreational use. In recent decades, the U.S. state of Oregon has had a number of legislative, legal, and cultural events surrounding use of cannabis. Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes. An attempt to recriminalize possession of small amounts of cannabis was turned down by Oregon voters in 1997.
The Runciman Report was published by in 2000 by the UK policing think tank the Police Foundation which hosted an inquiry into the United Kingdom's Misuse of Drugs Act 1971 (MDA). The report was authored by Viscountess Ruth Runciman.
These drugs are known in the UK as controlled drug, because this is the term by which the act itself refers to them. In more general terms, however, many of these drugs are also controlled by the Medicines Act 1968, there are many other drugs which are controlled by the Medicines Act but not by the Misuse of Drugs Act, and some other drugs are controlled by other laws.
Cannabis is a plant used in Australia for recreational, medicinal and industrial purposes. In 2019, 36% of Australians over the age of fourteen years had used cannabis in their lifetime and 11.6% had used cannabis in the last 12 months.
The Drug Equality Alliance is a non-profit organisation based in the United Kingdom whose mission statement is:
[...] It is made to transform the "War on Some People who use Some Drugs" from its subjective historical and cultural roots into a rational and objective legal regulatory framework that secures equal rights and equal protection to all those who are concerned with dangerous or otherwise harmful drugs. Our mission is to use domestic and international legal jurisdictions to interrogate the law and its application to those who produce, commerce, possess and consume such drugs.
Drugs considered addictive or dangerous in the United Kingdom are called "controlled substances" and regulated by law. Until 1964 the medical treatment of dependent drug users was separated from the punishment of unregulated use and supply. Under this policy drug use remained low; there was relatively little recreational use and few dependent users, who were prescribed drugs by their doctors as part of their treatment. From 1964 drug use was decreasingly criminalised, with the framework still in place as of 2014 largely determined by the Misuse of Drugs Act.
Cannabis in Seychelles is illegal, with cultivation, possession and sale of the substance banned. Regardless of this, the controlled substance has seen continual use within Seychelles, with statistics indicating that more than a quarter of the nation's population are users of the drug, as well as use evident amongst adolescents. The drug is ingested in a variety of forms for medicinal or recreational use.
Cannabis in Antigua and Barbuda is illegal but decriminalized. The islands are not a major producer of cannabis, and instead import the drug from Jamaica and Saint Vincent and the Grenadines.
Cannabis in Brunei is illegal and can be punishable by caning or the death penalty. Brunei Darussalam's legislation is controlled by its sultan and is based on the country's Sharia-Islamic beliefs. In accordance with these laws, Brunei native, Lam Ming Hwa, received the death sentence in 2004 and a Malaysian native, Muhammad Mustaqim Mustofa bin Abdullah, was sentenced to death in 2017.
The home secretary is one of the most senior and influential ministers in the UK Government, and the holder of a Great Office of State. The home secretary's remit includes law enforcement in England and Wales, matters of national security, issues concerning immigration, and oversight of the Security Service (MI5).
{{cite journal}}
: Cite journal requires |journal=
(help)